CORPORATE ANNOUNCEMENT

  • Media Release dated 22.04.2024
  • Intimation Incorporation LLC dated 19.04.2024
  • Postal Ballot Notice dated 20.03.2024
  • Media Releases dated 26.02.2024
  • Media Releases dated 21.02.2024
  • Media Releases dated 19.02.2024
  • Media Releases dated 16.02.2024
  • Media Releases dated 14.02.2024
  • Outcome of Fund Raising Committee dated 10.02.2024
  • Media Release dated 09.02.2024
  • Media Release dated 06.02.2024
  • Media Release dated 03.02.2024
  • Media Release dated 02.02.2024
  • Media Release dated 31.01.2024
  • Media Release dated 22.01.2024
  • Media Release dated 18.01.2024
  • Media Release dated 13.01.2024
  • Media Release dated 03.01.2024
  • AGM Notice
  • Annual secretarial Compliance Report for the year ended March 31, 2022
  • Media Release dated March 06,2023
  • Second Reminder cum forfeiture notice_28.02.2023
  • Second And Final Reminder-Cum Forfeiture Notice_28.02.2023
  • Media Release - Financial Performance - 9M FY23 And Strategic Investment In Kohinoor Foods Limited_25.01.2023
  • Outcome of Board Meeting_25.01.2023
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 - 23.01.2023
  • Intimation of Board Meeting_25.01.2023
  • Media Release - Vikas Lifecare Limited Infra Materials Division Fetches Fresh Orders For INR 160 Million_18.01.2023
  • Media Release - DSIR Recognition To Vikas Lifecare'S In-House R&D Unit(S)_16.01.2023
  • Closure of Trading Window_30.12.2022
  • Media Release - Vikas Lifecare''s Material Subsidiary Genesis Gas Solution_19.12.2022
  • Outcome Of Board Meeting_24.11.2022
  • Announcement under Regulation 30 (LODR)-Qualified Institutional Placement_15.11.2022
  • Media Release -Disclosure under Regulation 30 of SEBI (LODR) 2015 - 11.11.2022
  • Compliance pursuant to Regulation 23(9) of SEBI (LODR),2015 - 03.11.2022
  • Annexure acquisition_28.10.2022
  • Financial results_21.10.2022
  • Board Meeting Outcome_21.10.2022
  • Annexure aquisition_19102022
  • Annexure aquisition_15102022
  • Regulation 74(5)_14.10.2022
  • Media Release_14.10.2022
  • Annexure to the Media Release_10.10.2022
  • Media Release- Vikas Lifecare Limited acquires 30% stake in Retail Chain Stores Ardh Sainik Canteen for cash consideration of INR 150 Million
  • TradingWindowClosure_30.09.2022
  • Scrutinizer Report_29.09.2022
  • AGM Proceeding_29.09.2022
  • Notice of Annual General Meeting _29.09.2022
  • BookClosure_03.09.2022
  • Outcome of Board Meeting_03.09.20221
  • Outcome with List o Allottee_24082022
  • Outcome of QIP Meeting_24.08.2022
  • Committee Meeting Outcome_17.08.2022
  • Resignation Auditor_06.08.2022
  • MediaRelease_26.07.2022
  • Financial Results_25.07.2022
  • Outcome of Board Meeting_25.07.2022
  • Disclosure under 74(5)_08.07.2022
  • Closure of trading window_30.06.2022
  • Disclosure Regulation 30, LODR 2015_22.06.2022
  • Media Release Adds Almonds and Walnuts11.06.2022
  • Disclosure Regulation 23(9) LODR, 2015_11.06.2022
  • Announcement under Regulation 30 (LODR)-Allotment 02.06.2022
  • Announcement under Regulation 30 (LODR)-Qualified Institutional Placement - 02.06.2022
  • Media Release - 06.03.2023
  • Postal Ballot Notice
  • Composite Application Form
  • Right Entitlement Letter
  • Abridged Letter of Offer
  • Letter of Offer
  • Abridged Letter of Offer
  • Composite Application Form
  • Letter of Offer - Right Issue
  • Revised disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011_21.01.2021
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011_20.01.2021
  • Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011_18.01.2021
  • Announcement under Regulation 30 (LODR)-Newspaper Publication_12.01.2021
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
  • Outcome Of The Board Meeting Held On January 12, 2021
  • Announcement under Regulation 30 (LODR)-Newspaper Publication_Board Meeting Intimation

Disclaimer

 

ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBPAGE BY VIKAS LIFECARE LIMITED (THE “COMPANY”) IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY.

IMPORTANT: You must read the following disclaimer carefully before continuing – it applies to all persons who view this webpage. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the site. The following disclaimer applies to the Preliminary Placement Document for the private placement of equity shares (“Equity Shares”) of Vikas Lifecare Limited (the “Company”) (“Issue”) filed with the BSE Limited and the National Stock Exchange of India Limited. You are advised to read this disclaimer carefully before reading, accessing or making any other use of the Preliminary Placement Document. The Preliminary Placement Document is available for you to read on screen and to print in PDF format. By accessing the Preliminary Placement Document, you agree to follow the following terms and conditions, including any modifications to them from time to time.

1.1 The issue and distribution of the Preliminary Placement Document and the placement of the Company’s shares (the “Shares”) is being done in reliance on Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI Regulations”), and Section 42 of the Companies Act, 2013 and the rules thereunder, and is meant only for qualified institutional buyers (as defined under SEBI Regulations)(“QIBs”) on a private placement basis and is not an offer to the public or to any other class of investors to sell, solicit or recommend the sale or purchase of the Shares. No offer is being made to the public or to any other category of investors.

 

 

1.2 The Preliminary Placement Document has not been and will not be registered as a prospectus with any Registrar Of Companies in India under the Companies Act, 2013. The Preliminary Placement Document has not been and will not be reviewed or approved by any regulatory authority in India, including the Securities and Exchange Board of India, the Reserve Bank of India, any Registrar of Companies in India or any stock exchange in India. The Preliminary Placement Document is not and should not be construed as an invitation, offer or sale of any securities to the public in any jurisdiction, including India.

 

No Shares will be offered or deemed to be offered in India or overseas to the public or any member of the public in India or any class of investors other than QIBs, who have been delivered a pre-numbered Preliminary Placement Document addressed to and inviting such QIB to submit an application form. The names and contact details of all the QIBs who receive the Preliminary Placement Document along with the application form shall be submitted to the relevant Registrar of Companies and SEBI, as required by the Companies Act, 2013.

 

 

1.3 You may not and are not authorized to (1) deliver the Preliminary Placement Document to any other person, in whole or in part or otherwise provide access via e-mail or otherwise to any other person or (2) reproduce the Preliminary Placement Document in any manner whatsoever. Failure to comply with this directive may result in a violation of the SEBI Regulations or other applicable laws of India.

 

1.4 The Preliminary Placement Document does not constitute or form a part of any offer or solicitation to purchase or subscribe for the Equity Shares in the United States or in any jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offer and sale of the Equity Shares has not been and will not be registered under the U.S. Securities Act of 1933 (the “Securities Act”), and the Equity Shares may not be offered or sold, directly or indirectly, within the United States except pursuant to a transaction exempt from or not subject to the registration requirements of the Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States. There will be no offering of the Equity Shares in the United States. The Equity Shares are only being offered and sold outside the United States in compliance with Regulation S under the Securities Act and the applicable laws of the jurisdictions where the Equity Shares are offered and sold. The Equity Shares will also not be registered under the applicable securities laws of any state, province, territory, county or jurisdiction of Australia, Canada, The People’s Republic of China or Japan. Accordingly, the Equity Shares may not be offered or sold, directly or indirectly, in or into Australia, Canada, The People’s Republic of China or Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction.

 

1.5 None of the Company, the Book Running Lead Manager (as defined in the Preliminary Placement Document) or any of their respective affiliates, directors, officers, employees, agents, representatives or advisers accepts any liability whatsoever for any loss howsoever arising from any use of this website or the attached Preliminary Placement Document or their respective contents or otherwise arising in connection therewith.

 

1.6 You are responsible for protecting against viruses and other destructive items. Your use of this website is at your own risk and it is your responsibility to take precautions to ensure that it is free from viruses and other items of a destructive nature.

Scroll to Top